TAF I p48 inhibitors constitute a class of chemical compounds designed to target and modulate the activity of the TAF I p48 protein. TAF I p48, which stands for TATA-binding protein-associated factor I p48, is a subunit of the TFIID complex, a multiprotein assembly that plays a central role in the initiation of transcription in eukaryotic cells. Specifically, TAF I p48 is involved in the regulation of transcriptional activity by functioning as a coactivator that interacts with the TATA-binding protein (TBP) and contributes to the formation of the transcription initiation complex at gene promoters. Inhibitors of TAF I p48 are developed to interfere with its coactivator functions or other activities, affecting the transcriptional processes and gene expression regulated by this protein.
The mechanisms by which TAF I p48 inhibitors function can vary based on their chemical structures and binding properties. Some inhibitors may directly interact with TAF I p48, disrupting its ability to bind to TBP or other components of the transcription initiation complex. Others may modulate the conformation or stability of TAF I p48, affecting its coactivator functions and its role in gene transcription. By inhibiting TAF I p48, these compounds influence the transcriptional regulation of various genes, impacting processes such as cell differentiation, development, and response to environmental cues. Ongoing research in this field aims to uncover the precise mechanisms and downstream effects of TAF I p48 inhibition, furthering our understanding of its role in cellular biology and gene expression.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine, a DNA methylation inhibitor, may influence TAF I p48 expression by altering epigenetic marks and affecting gene expression. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Vorinostat, a histone deacetylase inhibitor, could potentially affect TAF I p48 expression through epigenetic modulation of chromatin structure. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A, another histone deacetylase inhibitor, might impact TAF I p48 expression by altering chromatin accessibility and gene transcription. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Bortezomib, a proteasome inhibitor, may modulate TAF I p48 expression by affecting protein degradation pathways and cellular stress responses. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
MG132, another proteasome inhibitor, could influence TAF I p48 expression by interfering with protein turnover and cell cycle regulation. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
Decitabine, a DNA hypomethylating agent, may affect TAF I p48 expression by changing the methylation status of genes and impacting transcription. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $90.00 $212.00 | 24 | |
Entinostat, another histone deacetylase inhibitor, could potentially modulate TAF I p48 expression through epigenetic changes affecting gene expression. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $58.00 $186.00 $94.00 | 21 | |
Camptothecin, a topoisomerase inhibitor, might impact TAF I p48 expression by interfering with DNA replication and transcription processes. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $51.00 $231.00 $523.00 | 63 | |
Etoposide, another topoisomerase inhibitor, may influence TAF I p48 expression by affecting DNA damage response and transcriptional regulation. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $231.00 $863.00 | 1 | |
JQ1, a BET bromodomain inhibitor, could alter TAF I p48 expression through its impact on chromatin dynamics and gene transcription. | ||||||